Invention Grant
US08647626B2 Compositions comprising TNF-specific antibodies for oral delivery
失效
包含用于口服递送的TNF特异性抗体的组合物
- Patent Title: Compositions comprising TNF-specific antibodies for oral delivery
- Patent Title (中): 包含用于口服递送的TNF特异性抗体的组合物
-
Application No.: US13912569Application Date: 2013-06-07
-
Publication No.: US08647626B2Publication Date: 2014-02-11
- Inventor: Barbara S. Fox
- Applicant: Avaxia Biologics, Incorporated
- Applicant Address: US MA Lexington
- Assignee: Avaxia Biologics, Incorporated
- Current Assignee: Avaxia Biologics, Incorporated
- Current Assignee Address: US MA Lexington
- Agency: Elmore Patent Law Group, P.C.
- Agent Darlene A. Vanstone; Carolyn S. Elmore
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
In accordance with the invention, the development and use of antibodies within the digestive tract is provided. Antibodies are described that are used to treat disorders associated with altered permeability of the digestive tract. Antibodies are described with increased stability within the environment of the digestive tract. Antibodies are described with enhanced permeability to a compromised digestive tract.
Public/Granted literature
- US20130337018A1 ANTIBODY THERAPY FOR USE IN THE DIGESTIVE TRACT Public/Granted day:2013-12-19
Information query
